Abstract

BackgroundMBLs form a large and heterogeneous group of bacterial enzymes conferring resistance to β-lactam antibiotics, including carbapenems. A large environmental reservoir of MBLs has been identified, which can act as a source for transfer into human pathogens. Therefore, structural investigation of environmental and clinically rare MBLs can give new insights into structure–activity relationships to explore the role of catalytic and second shell residues, which are under selective pressure.ObjectivesTo investigate the structure and activity of the environmental subclass B1 MBLs MYO-1, SHD-1 and ECV-1.MethodsThe respective genes of these MBLs were cloned into vectors and expressed in Escherichia coli. Purified enzymes were characterized with respect to their catalytic efficiency (kcat/Km). The enzymatic activities and MICs were determined for a panel of different β-lactams, including penicillins, cephalosporins and carbapenems. Thermostability was measured and structures were solved using X-ray crystallography (MYO-1 and ECV-1) or generated by homology modelling (SHD-1).ResultsExpression of the environmental MBLs in E. coli resulted in the characteristic MBL profile, not affecting aztreonam susceptibility and decreasing susceptibility to carbapenems, cephalosporins and penicillins. The purified enzymes showed variable catalytic activity in the order of <5% to ∼70% compared with the clinically widespread NDM-1. The thermostability of ECV-1 and SHD-1 was up to 8°C higher than that of MYO-1 and NDM-1. Using solved structures and molecular modelling, we identified differences in their second shell composition, possibly responsible for their relatively low hydrolytic activity.ConclusionsThese results show the importance of environmental species acting as reservoirs for MBL-encoding genes.

Highlights

  • The class B MBLs are enzymes with the ability to hydrolyse virtually all b-lactam antibiotics, including carbapenems.[1]

  • The sequence identity of MYO-1, ECV-1 and SHD-1 was as low as 28% compared with the widespread MBL NDM-1 (Figure 1)

  • SHD-1 conferred the highest increase in carbapenem MICs, with a 64, 4- and 1024-fold increase for ertapenem, imipenem and meropenem, respectively

Read more

Summary

Introduction

The class B MBLs are enzymes with the ability to hydrolyse virtually all b-lactam antibiotics, including carbapenems.[1] Various MBLs, including NDM, VIM and IMP, are associated with mobile genetic elements and widespread among clinically important Gramnegative pathogens. MBLs form a large and heterogeneous group of bacterial enzymes conferring resistance to b-lactam antibiotics, including carbapenems. A large environmental reservoir of MBLs has been identified, which can act as a source for transfer into human pathogens. Structural investigation of environmental and clinically rare MBLs can give new insights into structure–activity relationships to explore the role of catalytic and second shell residues, which are under selective pressure

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call